Navigation Links
Enbrelr Enters Safer Zone After Recent Research

Latest studies have declared ENBRELR (etanercept) safe to be used to treat psoriasis up to an extended period of two and half years//. The result of the current studies were presented at the 15th European Academy of Dermatology and Venereology (EADV)Congress . ENBREL is a 'Biologic Medicine which means it is synthesized using recombinant DNA or rDNA derived protein using current principles of biotechnology.

This biologic medicine acts by inhibiting one of the main mediators which triggers off inflammatory processes. Enbrel happens to be topmost biologic therapeutic clinically approved worldwide, It is also less cumbersome for patients as it is marketed in convenient 25mg and 50mg syringes making it most adaptable for treatment purposes.

Bruce Strober MD PhD, co director of the Psoriasis and Psoriatic Arthritis Center at New York University mentions that that these findings are very significant as it confirms the parameters within which Enbrel is safe to be used, and also provides valuable information regarding the use of other biologic medicines as well in the long run.

About 5.1 million people is affected by Psoriasis in U.K alone, according to statistics. The most common type of Psoriasis presents itself in the form of plaques over affected skin surface characterized by thickening of skin which looks reddish with superfluous flaky white scales which fall away on being scratched. Most common symptoms associated with these lesions are severe intolerable itching and redness of skin apart from the drying and scaling away of skin. It is probable that an abnormal response from the immune system of the body cause the skin cells to grow and multiply excessively.

In the 48 week Open Label study that was conducted it was clear that ENBREL produced no unpalatable side effects with extended dosages upto2.5 years when compared with randomized Placebo controlled Parent Studies. No further safety signals were iden tified. These findings support the conclusions derived from previous research done giving ENBREL50mg twice a week in a 96-week study.
MON
'"/>




Related medicine news :

1. More Doctors Suspended As Strike Enters Seventh Day
2. Doctors Strike In Andhra Enters The Second Day
3. Anti-Quota Stir: Stalemate Continues; Fast Enters 10th Day
4. AIIMS Strike Enters Second day, Support Continues To Pour In
5. JIPMER Strike Enters Eighth Day
6. The Food Pyramid Guide Enters Supermarkets
7. Vandetanib Study Enters Third Phase
8. Crucells Rabies MAb Enters Phase I Trial in India
9. Heart Surgery Is Getting Safer for the Old
10. Estrogen Patch is Safer than Pills for Heart
11. Traffic Violations Result in Safer Drivers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, a nationwide ... Select certification and SMB specialization. Altura is now qualified to sell, install ... the Select Certification, Altura fulfilled the training and exam requirements for the Cisco ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... named PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the ... in providing information destruction , recycling, and compliance services to businesses ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... role as Vice President of Sales and Business Development at OAKWORKS, Inc. ... partner engagements, business development, and strategic planning for the company. Recognized industry-wide ...
(Date:4/21/2017)... ... 21, 2017 , ... An April 10 article in the Daily ... reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, no ... to remove decayed dental matter, and that teeth were then filled with bitumen, a ...
(Date:4/21/2017)... ... ... staff at Palm Beach Face is proud to announce that their practice founder, Michael ... take place on April 23rd, the London Marathon has a long tradition of raising funds ... team EMPOWER, raising money for the international charity, Smile Train. , Started in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology: